Japan’s Taisho declines at home but grows overseas
Premium
17 May 2021
Taisho Pharmaceutical’s Self-Medication division recorded mixed results in the 12 months ended 31 March 2021, with sales in its home market of Japan dropping by a tenth but overseas sales increasing by a third.
